Ngenla - European Medicines Agency (EMA)
www.ema.europa.eu
Ngenla can only be obtained with a prescription and treatment should be started and monitored by a doctor experienced in the management of children and adolescents with growth hormone deficiency. Ngenla is available as an injection in pre-filled pens of different strengths, to be given under the skin once a week. The recommended dose is 0.66 mg per kilogram of body weight each week, adjusted ...
ПРИЛОЖЕНИЕ I КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА
www.ema.europa.eu
Промяна на деня на приложениена дозата Ако е необходимо, денят на седмичното приложение може дасе промени, при условие че времето между двете дози е най-малко 3дни. След избиране на нов ден на приложение, лечението ...
Somatrogon - Wikipedia
en.m.wikipedia.org
Somatrogon, sold under the brand name Ngenla, is a medication for the treatment of growth hormone deficiency. [1][6][8] Somatrogon is a glycosylated protein constructed from human growth hormone and a small part of human chorionic gonadotropin which is appended to both the N-terminal and C-terminal. [8] Somatrogon is a human growth hormone analog. [6] The most common side effects include ...